>
Global Bond Market On Edge As Japanese Yields Soar After "Horrible" 10Y JGB Auction
Caterpillar Erupts As Quarterly Sales Top $20 Billion For First Time Amid AI Data Center Boom
Iran Gets Another "Last Chance" – How Many Are We Up To Now?
Democrats Express Concern Over Increase In Gun Violence Against Active Shooters
Voyager 1 approaches one light day from Earth
Renewable Energy Breakthrough! World's Most Efficient Tesla Turbine System
Meet Sunbird, a nuclear fusion-powered space tug concept from Pulsar Fusion.
China and Russia launch 29-nation AI alliance to rival western control of technology
BREAKING: China has begun manufacturing domestically developed Immersion Deep...
Idaho's High Desert Becomes Hot Spot For Nuclear Power Revolution
The World's Largest Electric Aircraft Is About to Take Its First Flight
Tesla Cybercabs and Superchargers Will Act as Mini Cell Towers for SpaceX Starlink

Two proteins, amyloid and tau, clump together and smother neurons, causing memory loss and confusion in Alzheimer's patients
Another protein called VPS35, clears the destructive proteins, but levels of the helpful compound are low in Alzheimer's patients
Researchers used a newly-developed drug to boost levels of VPS35 in the brains of some mice genetically engineered to develop the age-related disease
Treated mice had less tau and amyloid beta proteins and performed better on tests of memory and learning